Oncology - European Medical Journal

Continue

Oncology

Filter
EMJ
18 May 2015

Rise in Deadly Skin Cancer is by No Means Old News

SENIOR citizens in Britain are approximately seven times more likely to develop malignant melanoma than they were 40 years ago, according to new statistics.
EMJ
11 May 2015

The Scottish Medicines Consortium Approves Gilead’s Zydelig® q (Idelalisib) for the Treatment of Follicular Lymphoma That Is Refractory to Two Prior Lines of Treatment in Adult Patients

Foster City, CA, 11 May 2015 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Scottish Medicines Consortium (SMC) has approved Zydelig…
EMJ
17 Apr 2015

One in Four Advanced Lung Cancer Patients Tested for EGFR Mutations Started on First-Line Treatment Before Test Results Available

Geneva, Switzerland, 17 April 2015 — Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving…
EMJ
17 Apr 2015

Evidence Grows That Melanoma Drugs Benefit Some Lung Cancer Patients

Geneva, Switzerland, 17 April 2015 — A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to…
EMJ
17 Apr 2015

New Real-World Clinical Practice Study Highlights the Value of the Oncotype DX® Breast Cancer Test for Patients, Physicians and the Health Care System

Studies present results from a real-life observational study in Ireland demonstrating significant reductions in chemotherapy and resulting cost-savings when the test is used in early stage breast cancer.
EMJ
25 Feb 2015

Living with a Rare Cancer

Lugano, 25 February 2015 – Within the “umbrella” of rare diseases, rare cancer patients confront particular problems. Most rare diseases have an…
EMJ
23 Feb 2015

Combination Therapy Trial for Breast Cancer

BREAST cancer patients with small node-negative HER2-positive tumours achieved 3-year survival approaching 100% with adjuvant paclitaxel and trastuzumab…
EMJ
23 Feb 2015

Anti-Cancer Transformers: The next Generation Self-Assembling Arsenal

PROGRAMMABLE biomaterial that is capable of spontaneously assembling into a fighting structure once injected into a living body has the potential to…